JAZZ vs MCHPP · P/E 1988, rev $4.07B vs rev $4.40B
Jazz Pharmaceuticals PLC (JAZZ) versus Microchip Technology Incorporated (MCHPP) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Microchip Technology Incorporated (MCHPP) is a semiconductors company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported MCHPP revenue for 2025-03-31 was $4.40B. Net income was -$500.0K. Revenue was down 42.3% from 2024-03-31 to 2025-03-31. MCHPP currently screens at market cap $0.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. MCHPP currently screens at market cap $0.
Not investment advice. Open the JAZZ and MCHPP stock pages for the full models.
Not investment advice.